Parallel Advisors’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
28,822
+3
+0% +$120 0.02% 464
2026
Q1
$1.04M Buy
28,819
+2,044
+8% +$78.4K 0.02% 465
2025
Q4
$1.03M Sell
26,775
-3,163
-11% -$119K 0.02% 433
2025
Q3
$1.08M Hold
29,938
0.02% 406
2025
Q2
$1.03M Sell
29,938
-13,812
-32% -$438K 0.02% 411
2025
Q1
$1.37M Buy
43,750
+7,865
+22% +$257K 0.03% 328
2024
Q4
$1.15M Buy
35,885
+5,386
+18% +$175K 0.03% 362
2024
Q3
$995K Buy
30,499
+3,440
+13% +$108K 0.02% 388
2024
Q2
$839K Buy
27,059
+22,413
+482% +$668K 0.02% 395
2024
Q1
$138K Buy
4,646
+4,296
+1,227% +$122K ﹤0.01% 1027
2023
Q4
$9.32K Buy
+350
New +$9.1K ﹤0.01% 2318

Other funds holding QLTY

Parallel Advisors's QLTY Position: Q2 2026 in Review

Parallel Advisors increased its GMO US Quality ETF (QLTY) stake by 0.01% in Q2 2026, buying an estimated $120 and bringing the position to 28,822 shares worth $1.2M. The position accounts for 0.02% of the portfolio, ranked #464.

Parallel Advisors first reported a position in QLTY in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.37M in Q1 2025. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Parallel Advisors held 28,822 shares of GMO US Quality ETF worth $1.2M as of Q2 2026.
  • Parallel Advisors bought 3 GMO US Quality ETF shares in Q2 2026, an estimated $120.
  • GMO US Quality ETF made up 0.02% of Parallel Advisors's portfolio in Q2 2026, its #464 holding.
  • Parallel Advisors first reported a position in GMO US Quality ETF in Q4 2023 and has held it in 11 quarters since.
  • Parallel Advisors's GMO US Quality ETF position peaked at $1.37M in Q1 2025.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.